Lethal drugs leaked in botched Oklahoma execution: report

Fri Jun 13, 2014 2:53pm EDT

Related Topics

(Reuters) - Oklahoma failed to properly insert an intravenous line to deliver lethal drugs to an inmate during a botched execution in April, bypassing strong veins in his arms and using a riskier entry point in the groin area, according to a preliminary autopsy released on Friday by the inmate's lawyers.

Convicted murderer and rapist Clayton Lockett died, apparently of a heart attack, about 30 minutes after prison officials halted the execution, having failed to properly administer the lethal injection. Prison officials drew a curtain to cut off a view to witnesses about 15 minutes into the procedure, as Lockett was squirming on a death chamber gurney.

The White House criticized the execution as being beyond humane standards. No execution has been held in the United States since then, with courts granting stays for various reasons to those who were scheduled to be put to death in the weeks that followed.

"Contrary to statements by the state, Mr. Lockett's veins did not collapse or 'blow out'," lawyers for Lockett said.

The independent report by forensic pathologist Joseph Cohen found Lockett's veins, both surface and deep, were in excellent shape "for the purpose of achieving venous access," it said.

There were skin punctures on Lockett's left and right arms, indicating that prison officials tried and failed to insert an IV in both arms and then set an IV in the groin area, which would typically be more painful, the autopsy report said.

Oklahoma officials did not comment, saying they will have the results of their own independent autopsy in a few weeks.

The state also came under criticism for using a new, three-drug cocktail in the lethal injection, with lawyers saying the mix may have caused undue pain, in violation of U.S. constitutional protections against cruel and unusual punishment.

Oklahoma set up a new lethal injection procedure earlier this year, after it was no longer able to obtain the drugs it had once used for executions.

Oklahoma and other states have been scrambling to find new suppliers and chemical combinations after drug makers, mostly in Europe, imposed sales bans because they objected to having medications originally made for other purposes being used in executions.

Lockett, 38, was convicted of first-degree murder, rape, kidnapping and robbery for a 1999 crime spree with two co-defendants. He was shot teenager Stephanie Nieman and buried her alive in a shallow grave, where she eventually died.

(Writing by Jon Herskovitz; editing by Gunna Dickson)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
REnninga wrote:
America’s “red states” certainly do expend a lot of time, money, effort and energies toward what is, by definition, the “premeditated murder of human beings.”

One would think that some reflection would be in order, and acknowledgement that largely with the exception of totalitarian dictatorships, military juntas, Marxist states, failed states and backward 3rd world nations, most of the rest of the world has already turned away from this barbaric practice.

Nations which have used capital punishment within past 10-years:

Afghanistan ·
Bangladesh ·
Belarus ·
Botswana ·
China ·
Egypt ·
India ·
Indonesia ·
Iran ·
Iraq ·
Japan ·
North Korea ·
Lebanon ·
Malaysia ·
Pakistan ·
Saudi Arabia ·
Singapore ·
Somalia ·
Syria ·
Taiwan ·
Tonga ·
United Arab Emirates ·
United States ·
Uzbekistan ·
Vietnam ·
Yemen

Quite a list. Should this make us proud? We are only as good as the company we keep.

Jun 13, 2014 4:17pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.